# Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

Study · id `cardio:ct-nct07324031` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07324031](<https://clinicaltrials.gov/study/NCT07324031>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07324031

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 280 participants.

## Technical summary

Registry record NCT07324031. Allocation not applicable; no masking; primary purpose treatment. Start 2026-07-02 (actual); primary completion 2027-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 280 participants (planned count; ClinicalTrials.gov record NCT07324031, source copy `cardio:ctgov-nct07324031-2026-11-17`, retrieved 2026-11-18)
- Started: 2026-07-02 (actual) (ClinicalTrials.gov record NCT07324031, source copy `cardio:ctgov-nct07324031-2026-11-17`, retrieved 2026-11-18)
- Primary completion: 2027-08-31 (anticipated) (ClinicalTrials.gov record NCT07324031, source copy `cardio:ctgov-nct07324031-2026-11-17`, retrieved 2026-11-18)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07324031, source copy `cardio:ctgov-nct07324031-2026-11-17`, retrieved 2026-11-18)
- Countries: United States; Netherlands (ClinicalTrials.gov record NCT07324031, source copy `cardio:ctgov-nct07324031-2026-11-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07324031-2026-11-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
- Acronym: ALARION EV
- Condition: Ventricular Arrythmia
- Condition: Ventricular Fibrillation
- Condition: Ventricular Tachycardia
- Intervention (Device): Atala™ lead and EV-ICD Pulse Generator
- Lead sponsor: AtaCor Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)

## Provenance

Content hash: 15508e01e7bbe2ddc353fcb52d1de963ad0a15f5f652d6dd60e9fe63307a29f9
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
